Research output per year
Research output per year
Personal profile
Research interests
Research Interest
Education/Academic qualification
PhD, Cell Cycle Control in CHO cells, Utrecht University
1 Sept 1995 → 30 Apr 2000
Award Date: 17 Apr 2000
Master, Leiden University
1987 → 1993
External positions
Associate Professor, Amsterdam UMC
2018 → …
Keywords
- RC0254 Neoplasms. Tumors. Oncology (including Cancer)
- Pediatric cancer
- high-grade glioma
- ATRT
- Ependymoma
- Epigenetics
- H3K27M
- PDX models
- CRISPR/Cas9
- Drug screens
- Brain tumor
- DMG
- DIPG
- Diffuse midline glioma
Fingerprint
Dive into the research topics where Esther Hulleman is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Gemcitabine therapeutically disrupts essential SIRT1-mediated p53 repression in atypical teratoid/rhabdoid tumors
Metselaar, D. S., Meel, M. H., Goulding, J. R., du Chatinier, A., Rigamonti, L., Waranecki, P., Geisemeyer, N., de Gooijer, M. C., Breur, M., Koster, J., Veldhuijzen van Zanten, S. E. M., Bugiani, M., Franke, N. E., Reddy, A., Wesseling, P., Kaspers, G. J. L. & Hulleman, E., Sept 2024, In: Cell Reports Medicine. 5, 9, p. 101700Research output: Contribution to journal › Article › peer-review
Open Access -
OV Modulators of the Paediatric Brain TIME: Current Status, Combination Strategies, Limitations and Future Directions
Vazaios, K., van Berkum, R., Calkoen, F. G., van der Lugt, J. & Hulleman, E., Jan 2024, In: International Journal of Molecular Sciences. 25, 9Research output: Contribution to journal › Article › peer-review
Open Access -
The heterogeneous sensitivity of pediatric brain tumors to different oncolytic viruses is predicted by unique gene expression profiles
Vazaios, K., Stavrakaki, Ε., Vogelezang, L. B., Ju, J., Waranecki, P., Metselaar, D. S., Meel, M. H., Kemp, V., van den Hoogen, B. G., Hoeben, R. C., Chiocca, E. A., Goins, W. F., Stubbs, A., Li, Y., Alonso, M. M., Calkoen, F. G., Hulleman, E., van der Lugt, J. & Lamfers, M. L. M., 20 Jun 2024, In: Molecular therapy. Oncology. 32, 2, p. 200804Research output: Contribution to journal › Article › peer-review
Open Access -
A review of the anti-tumor potential of current therapeutics targeting the mitochondrial protease ClpP in H3K27-altered, diffuse midline glioma
Jackson, E. R., Persson, M. L., Fish, C. J., Findlay, I. J., Mueller, S., Nazarian, J., Hulleman, E., van der Lugt, J., Duchatel, R. J. & Dun, M. D., 17 Aug 2023, (E-pub ahead of print) In: Neuro-Oncology.Research output: Contribution to journal › Article › peer-review
Open Access -
A road map for the treatment of pediatric diffuse midline glioma
ChadTough meeting group, 30 Nov 2023, In: Cancer Cell. 42, 1, p. 1-5 5 p.Research output: Contribution to journal › Article › peer-review
Prizes
-
AACR-Pezcoller Foundation Scholar-in-training Award
Hulleman, E. (Recipient), 2008
Prize: Honorary award
-
Activities
- 1 Membership of board
-
SIOPe (the European Society for Paediatric Oncology), High-grade glioma/DMG working group (External organisation)
Hulleman, E. (Chair)
2016 → 2024Activity: Membership › Membership of board